CTS Corp SEC Filings

CTS Corporation furnished an investor presentation outlining recent performance, strategy, and 2026 guidance. For the twelve months ended December 2025, revenue was $541.3 million with adjusted EBITDA margin of 22.8% and adjusted diluted EPS of $2.23.

The business is increasingly diversified: industrial revenue was $140 million (up 12% year over year), medical revenue $85 million (up 21%), and aerospace & defense revenue $83 million (up 20%), while transportation revenue was $234 million (down 7%). Diversified end markets now represent 57% of revenue.

CTS reported free cash flow of $86.4 million in 2025 and has returned about $300 million to shareholders since 2013 through dividends and repurchases. For 2026, the company targets revenue of $550–$580 million and adjusted diluted EPS of $2.30–$2.45, supported by secular trends in automation, healthcare innovation, and electrification.

CTS Corporation reported stronger results for the fourth quarter and full year 2025, driven by growth in diversified industrial, medical, and aerospace & defense markets and better profitability. Fourth-quarter sales were $137.3 million, up 9% year over year, with diversified end markets up 16% and transportation down 1%. Net earnings rose to $19.7 million, and diluted EPS increased to $0.67 from $0.38, helped by higher gross and EBITDA margins.

For full-year 2025, sales reached $541.3 million, up 5%, while net earnings grew to $65.3 million and diluted EPS to $2.19 from $1.80. Diversified end markets grew 16% and represented 57% of revenue, partially offsetting a 7% decline in transportation revenue. Adjusted gross margin improved to 38.5% and adjusted EBITDA margin to 22.8%. Operating cash flow was $102.1 million and free cash flow $86.4 million, supporting $62 million returned to shareholders in 2025.

For 2026, CTS guides revenue of $550–$580 million and adjusted diluted EPS of $2.30–$2.45, assuming continued growth in diversified markets and softness in commercial-vehicle-related sales, with an expected tax rate of 21–23% excluding discrete items.

CTS Corporation President & CEO Kieran M. O'Sullivan reported a routine tax-related share withholding. On February 6, 2026, he surrendered 3,680 shares of common stock at $55.78 per share to cover tax obligations tied to vesting restricted stock.

After this transaction, O'Sullivan directly beneficially owned 410,730 shares of CTS common stock. The filing describes a non-open-market transaction classified as code F, which typically reflects shares withheld by the company rather than discretionary selling in the market.

CTS Corp's CFO Ashish Agrawal reported an automatic tax-withholding share surrender. On February 5, 2026, he surrendered 931 shares of CTS common stock at $54.19 per share to cover tax withholding upon vesting of restricted stock. Following this transaction, he directly beneficially owned 105,056 CTS shares.

CTS Corp Senior Vice President Pratik Trivedi reported an automatic share surrender to cover taxes. On February 5, 2026, Trivedi surrendered 289 shares of CTS common stock at $54.19 per share to satisfy tax withholding due on vesting of restricted stock. After this withholding transaction, Trivedi directly beneficially owned 8,063 CTS common shares.

CTS Corp chief financial officer Ashish Agrawal reported selling 25,000 shares of CTS common stock on 02/02/2026 at $53 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan entered into on February 27, 2025. Following this sale, Agrawal beneficially owns 105,987 CTS common shares directly.

CTS Corporation has a security holder who filed a Rule 144 notice to sell 25,000 shares of common stock through Merrill Lynch, with an aggregate market value of 1324250. These shares are part of 29,050,000 common shares outstanding, and the proposed sale date is 02/02/2026 on the NYSE.

The shares to be sold were acquired as stock bonuses from CTS Corporation on multiple dates in 2023 and 2024, with each grant fully paid on its respective grant date.

CTS Corporation reported a leadership change in its senior management team. On November 21, 2025, Martin Baumeister notified the company that he will resign from his role as Senior Vice President, effective at the close of business on December 5, 2025. The company states that his resignation is a personal decision to pursue another opportunity outside CTS and is not due to any disagreement with the company.

Effective the same date, December 5, 2025, CTS has appointed Pratik Trivedi, currently a Senior Vice President, as its new Chief Operating Officer. Trivedi, age 46, joined CTS in April 2024 and previously held leadership roles at Eaton Corporation plc and Cummins, Inc. CTS states that it did not enter into any material new plan or contract, nor did it change his compensation or grant equity in connection with this COO appointment.

CTS Corporation entered into a new five-year unsecured Credit Agreement providing a $300 million revolving credit facility with a bank syndicate led by Wells Fargo. The new facility replaces the company’s prior $400 million unsecured credit facility, which was terminated on November 24, 2025, after using initial borrowings to repay $63.3 million outstanding under the prior agreement.

The facility includes $20 million swing line and letter of credit sublimits and a $150 million alternative currency sublimit. Interest rates vary by loan type and are based on benchmark rates plus a margin tied to CTS’s net leverage ratio, and a quarterly commitment fee applies to unused capacity. Key covenants require a net leverage ratio not greater than 3.5 to 1.0, with a temporary step-up to 4.25 to 1.0 allowed around certain large acquisitions, and an interest coverage ratio of at least 3.0 to 1.